Mature dendritic cells pulsed with freeze-thaw cell lysates define an effective in vitro vaccine designed to elicit EBV-specific CD4(+) and CD8(+) T lymphocyte responses.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Blood

• Publication date

  2000-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1182/BLOOD.V96.5.1857PMID 10961887
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Natural adjuvants: Endogenous activators of dendritic cells

  1999cited by this paper
• Presentation of renal tumor antigens by human dendritic cells activates tumor-infiltrating lymphocytes against autologous tumor: implications for live kidney cancer vaccines.

  1999cited by this paper
• Identification of naturally processed and HLA-presented Epstein-Barr virus peptides recognized by CD4(+) or CD8(+) T lymphocytes from human blood.

  1999cited by this paper
• Human dendritic cells, pulsed with either melanoma tumor cell lysates or the gp100 peptide(280-288), induce pairs of T-cell cultures with similar phenotype and lytic activity.

  1998cited by this paper
• Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs

  1998cited by this paper
• Therapeutic vaccination against chronic viral infection: the importance of cooperation between CD4+ and CD8+ T cells.

  1998cited by this paper
• Vaccination of melanoma patients with peptide- or tumorlysate-pulsed dendritic cells

  1998cited by this paper
• Murine dendritic cells pulsed with whole tumor lysates mediate potent antitumor immune responses in vitro and in vivo.

  1998cited by this paper
• Dendritic cells and the control of immunity

  1998cited by this paper
• Immunization with a tumor-cell-lysate-loaded autologous-antigen-presenting-cell-based vaccine in melanoma

  1998cited by this paper
• Isolation of Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes that lyse Reed-Sternberg cells: implications for immune-mediated therapy of EBV+ Hodgkin's disease.

  1997cited by this paper
• Tumor Eradication by Wild-type p53-specific Cytotoxic T Lymphocytes

  1997cited by this paper
• Tumor antigens recognized by T cells.

  1997cited by this paper
• Presentation of exogenous protein antigens on major histocompatibility complex class I molecules by dendritic cells: pathway of presentation and regulation by cytokines.

  1997cited by this paper
• Pro‐inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum‐free conditions

  1997cited by this paper
• Origin, maturation and antigen presenting function of dendritic cells.

  1997cited by this paper
• The use of computer-assisted video image analysis for the quantification of CD8+ T lymphocytes producing tumor necrosis factor alpha spots in response to peptide antigens.

  1997cited by this paper
• Cloned dendritic cells can present exogenous antigens on both MHC class I and class II molecules.

  1997cited by this paper
• Regression of tumors in mice vaccinated with professional antigen‐presenting cells pulsed with tumor extracts

  1997cited by this paper
• A new foreign policy: MHC class I molecules monitor the outside world.

  1996cited by this paper
• New treatment options for patients with melanoma: review of melanoma-derived T-cell epitope-based peptide vaccines

  1996cited by this paper
• Dendritic cells process exogenous viral proteins and virus‐like particles for class I presentation to CD8+ cytotoxic T lymphocytes

  1996cited by this paper
• Murine dendritic cells loaded in vitro with soluble protein prime cytotoxic T lymphocytes against tumor antigen in vivo

  1996cited by this paper
• Immune intervention against virus-associated human cancers.

  1995cited by this paper
• Inactivated influenza virus, when presented on dendritic cells, elicits human CD8+ cytolytic T cell responses

  1995cited by this paper
• Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor.

  1995cited by this paper
• A peptide encoded by human gene MAGE‐3 and presented by HLA‐A2 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE‐3

  1994cited by this paper
• Identification of T-cell epitopes: rapid isolation of class I-presented peptides from viable cells by mild acid elution.

  1993cited by this paper
• Epstein-Barr virus latent gene transcription in nasopharyngeal carcinoma cells: coexpression of EBNA1, LMP1, and LMP2 transcripts

  1992cited by this paper
• Expression of epstein‐barr virus‐encoded growth‐transformation‐associated proteins in lymphoproliferations of bone‐marrow transplant recipients

  1991cited by this paper
• Expression of Epstein-Barr virus transformation-associated genes in tissues of patients with EBV lymphoproliferative disease.

  1989cited by this paper

• Therapeutic Anti-Tumor Efficacy of DC-Based Vaccines Targeting TME-Associated Antigens Is Improved When Combined with a Chemokine-Modulating Regimen and/or Anti-PD-L1

  2024cites this paper
• Investigating the effect of cGRP78 vaccine against different cancer cells and its role in reducing melanoma metastasis

  2024cites this paper
• Effect of Freeze–Thawing Treatment on Platelet-Rich Plasma Purified with Different Kits

  2024cites this paper
• Combined Autophagy Inhibition and Dendritic Cell Recruitment Induces Antitumor Immunity and Enhances Immune Checkpoint Blockade Sensitivity in Pancreatic Cancer

  2024cites this paper
• Activated T cell therapy targeting glioblastoma cancer stem cells

  2023cites this paper
• Synthetic Nano-selenium Improving Macrophage Immune Responses Treatment of Bladder Tumor Antigens

  2021cites this paper
• Adenoviral delivery of an immunomodulatory protein to the tumor microenvironment controls tumor growth

  2021cites this paper
• ELUCIDATING THE ROLE OF THE SATB1 GENE IN BREAST CANCER CARCINOGENESIS IN THE PRESENCE OR ABSENCE OF TOCOTRIENOL-RICH FRACTION: EVIDENCE FROM A SYNGENEIC MOUSE MODEL OF BREAST CANCER

  2021cites this paper
• Remission-Stage Ovarian Cancer Cell Vaccine with Cowpea Mosaic Virus Adjuvant Prevents Tumor Growth

  2021cites this paper
• Activated B lymphocytes and tumor cell lysate as an effective cellular cancer vaccine

  2021cites this paper
• The surface dominant antigen MUC1 is required for colorectal cancer stem cell vaccine to exert anti-tumor efficacy.

  2020cites this paper
• Development of Tumor Cell-Based Vaccine with IL-12 Gene Electrotransfer as Adjuvant

  2020cites this paper
• Biological Selenium Nano-particles Modify Immune Responses of Macrophages Exposed to Bladder Tumor Antigens

  2020cites this paper
• Palm Tocotrienol-Adjuvanted Dendritic Cells Decrease Expression of the SATB1 Gene in Murine Breast Cancer Cells and Tissues

  2019cites this paper
• Mechanisms, Predictors, and Challenges in Assessing and Managing Painful Chemotherapy-Induced Peripheral Neuropathy.

  2019cites this paper
• Current Approaches in Development of Immunotherapeutic Vaccines for Breast Cancer

  2018cites this paper
• Impact of Bee Venom Enzymes on Diseases and Immune Responses

  2016cites this paper
• A preliminary comparison of dendritic cell maturation by total cellular RNA to total cellular lysate derived from breast cancer stem cells

  2016cites this paper
• Rituximab-based treatments followed by adoptive cellular immunotherapy for biopsy-proven EBV-associated post-transplant lymphoproliferative disease in recipients of allogeneic hematopoietic stem cell transplantation

  2016cites this paper
• T cell differentiation by human parvovirus B19 non-structural protein 1 induced apoptotic bodies

  2015cites this paper
• Antitumor immunity triggered by melphalan is potentiated by melanoma cell surface-associated calreticulin.

  2015cites this paper
• Title: Anti-tumor immunity triggered by melphalan is potentiated by melanoma cell surface associated calreticulin

  2015cites this paper
• Apoptotic blebs from leukemic cells as a preferred source of tumor-associated antigen for dendritic cell-based vaccines

  2014cites this paper
• Understanding MHC Class I Presentation of Viral Antigens by Human Dendritic Cells as a Basis for Rational Design of Therapeutic Vaccines

  2014cites this paper
• Molecular mimicry of MAGE-A6 and Mycoplasma penetrans HF-2 epitopes in the induction of antitumor CD8+ T-cell responses

  2014cites this paper
• Devil Facial Tumour Disease: In vivo studies in mice

  2014cites this paper
• Epstein-Barr virus induces the differentiation of semi-mature dendritic cells from cord blood monocytes.

  2014cites this paper
• Cytokine and Chemokine Responses in Human Herpesvirus 8 Infection of Monocyte Derived Dendritic Cells and B Lymphocytes

  2013cites this paper
• Dendritic Cell-Based Immunotherapy for Myeloid Leukemias

  2013cites this paper
• Tocotrienol-Adjuvanted Dendritic Cells Inhibit Tumor Growth and Metastasis: A Murine Model of Breast Cancer

  2013cites this paper
• IMMUNOTHERAPEUTIC ACTION OF T-BET GENE MODIFIED DENDRITIC CELLS

  2013cites this paper
• Improving the in vivo Persistence, Distribution and Function of Cytotoxic T Lymphocytes by Inhibiting the Tumor Immunosuppressive Microenvironment

  2013cites this paper
• Professional antigen presenting cells in human herpesvirus 8 infection

  2013cites this paper
• CD8 T Lymphocyte Responses to Human Herpesvirus 8 Lytic and Latency Proteins

  2013cites this paper
• Varicella-zoster virus glycoproteins B and E are major targets of CD4+ and CD8+ T cells reconstituting during zoster after allogeneic transplantation

  2012cites this paper
• Développement de l'immunothérapie anti-tumorale médiée par vecteur bactérien vivant basé sur le système de sécrétion de type III de Pseudomonas aeruginosa

  2012cites this paper
• Effective posttransplant antitumor immunity is associated with TLR-stimulating nucleic acid-immunoglobulin complexes in humans.

  2011cites this paper
• Charakterisierung des Bax Inhibitor-1 Peptides als neues tumorassoziiertes T-Zellepitop

  2010cites this paper
• HLA-Identical Dendritic-Leukemic Cell Hybrids Generate Specific CTLs in Vitro

  2010cites this paper
• Dendritic cell responses to apoptotic cells : Is there life after death?

  2010cites this paper
• 8-pCPT-conjugated cyclic AMP analogs exert thromboxane receptor antagonistic properties

  2010cites this paper
• Preservation of dendritic cell function upon labeling with amino functionalized polymeric nanoparticles.

  2010cites this paper
• Identification of an HLA-A*0201-restrictive CTL epitope from MUC4 for applicable vaccine therapy

  2009cites this paper
• Dramatic efficacy improvement of a DC-based vaccine against AML by CD25 T cell depletion allowing the induction of a long-lasting T cell response

  2009cites this paper
• RNA-based immunotherapy of cancer: role and therapeutic implications of dendritic cells - Retracted

  2009cites this paper
• Ectopic T-bet Expression Licenses Dendritic Cells for IL-12-Independent Priming of Type 1 T Cells In Vitro1

  2009cites this paper
• Computational Prediction and Identification of Epstein-Barr Virus Latent Membrane Protein 2A Antigen-Specific CD8+ T-Cell Epitopes

  2009influential citation
• Dendritic cell-based immunotherapy in myeloid leukaemia: translating fundamental mechanisms into clinical applications.

  2009cites this paper
• EBV LMP2A-specific T Cell Immune Responses Elicited by Dendritic Cells Loaded with LMP2A Protein

  2009cites this paper
• Recovery of varicella-zoster virus-specific T cell immunity after T cell-depleted allogeneic transplantation requires symptomatic virus reactivation.

  2008influential citation
• A soluble hexameric form of CD40 ligand activates human dendritic cells and augments memory T cell response.

  2008cites this paper
• Reverse transcriptase inhibitors induce cell differentiation and enhance the immunogenic phenotype in human renal clear‐cell carcinoma

  2008cites this paper
• Comparison between Sendai virus and adenovirus vectors to transduce HIV‐1 genes into human dendritic cells

  2008cites this paper
• Potent Dendritic Cell Vaccine Loaded with Latent Membrane Protein 2A (LMP2A)

  2008cites this paper
• Inhibitory Effect of RNA Pool Complexity on Stimulatory Capacity of RNA-pulsed Dendritic Cells

  2008cites this paper
• Analysis and Characterization of Antitumor T-cell Response After Administration of Dendritic Cells Loaded With Allogeneic Tumor Lysate to Metastatic Melanoma Patients

  2008cites this paper
• Induction of anti-tumor immunity by lyophilized myeloma cells secreting GM-CSF.

  2007cites this paper
• Efficient Activation of Autologous Tumor-specific T Cells: A Simple Coculture Technique of Autologous Dendritic Cells Compared to Established Cell Fusion Strategies in Primary Human Colorectal Carcinoma

  2007cites this paper
• Antigen loading of dendritic cells with apoptotic tumor cell-preparations is superior to that using necrotic cells or tumor lysates.

  2007cites this paper
• Induction of tumor-specific T-cell responses by vaccination with tumor lysate-loaded dendritic cells in colorectal cancer patients with carcinoembryonic-antigen positive tumors

  2007cites this paper
• Divergence in CD8+ T cell epitopes of HIV -1 as an immune escape mechanism

  2007cites this paper
• 186: Superior antitumor in vitro responses of allogeneic matched sibling compared to autologous patient CD8+ T cells

  2007cites this paper
• In vitro induction of immune responses to shared tumor-associated antigens in rhabdomyosarcoma.

  2007cites this paper
• Induction of tumor-specific T-cell responses by vaccination with tumor lysate-loaded dendritic cells in colorectal cancer patients with carcinoembryonic-antigen positive tumors

  2007cites this paper
• Persistent IL-10 production is required for glioma growth suppressive activity by Th1-directed effector cells after stimulation with tumor lysate-loaded dendritic cells

  2007cites this paper
• DC-based vaccine loaded with acid-eluted peptides in acute myeloid leukemia: the importance of choosing the best elution method

  2006cites this paper
• Dendritic cells, pulsed with lysate of allogeneic tumor cells, are capable of stimulating MHC-restricted antigen-specific antitumor T cells

  2006cites this paper
• Identification of interleukin-13 receptor alpha2 peptide analogues capable of inducing improved antiglioma CTL responses.

  2006cites this paper
• Development of new polymer-based particulate systems for anti-glioma vaccination.

  2006cites this paper
• Superior antitumor in vitro responses of allogeneic matched sibling compared with autologous patient CD8+ T cells.

  2006cites this paper
• In vitro anti-tumor immune response induced by dendritic cells transfected with EBV-LMP2 recombinant adenovirus.

  2006cites this paper
• Proteasome-inhibited dendritic cells demonstrate improved presentation of exogenous synthetic and natural HLA-class I peptide epitopes.

  2006cites this paper
• Effect of dendritic cell vaccine against a tongue squamous cell cancer cell line (Tca8113) in vivo and in vitro.

  2006cites this paper
• Recombinant adenoviruses expressing TRAIL demonstrate antitumor effects on non-small cell lung cancer (NSCLC)

  2006cites this paper
• Effects of surgery, immunization, and laser immunotherapy on a non-immunogenic metastic tumor model

  2006cites this paper
• Polarized Dendritic Cells for Tumor Immunotherapy

  2005cites this paper
• RNA-Transfektion von dendritischen Zellen zur Induktion von antigenspezifischen zytotoxischen T-Lymphozyten

  2005cites this paper
• CD4 T cell control of acute and latent murine gammaherpesvirus infection requires IFNγ

  2005cites this paper
• Rapid Communication CD4 T cell control of acute and latent murine gammaherpesvirus infection requires IFNg

  2005cites this paper
• Autologous peptides eluted from acute myeloid leukemia cells can be used to generate specific antileukemic CD4 helper and CD8 cytotoxic T lymphocyte responses in vitro.

  2005cites this paper
• Uptake and presentation of malignant glioma tumor cell lysates by monocyte-derived dendritic cells

  2005influential citation
• CD 4 T cell control of acute and latent murine gammaherpesvirus infection requires IFN g

  2005cites this paper
• Semi-mature IL-12 secreting dendritic cells present exogenous antigen to trigger cytolytic immune responses

  2005cites this paper
• Apoptotic cells at the crossroads of tolerance and immunity.

  2005cites this paper
• New developments in dendritic cell–based vaccinations: RNA translated into clinics

  2005cites this paper
• CD4 T cell control of acute and latent murine gammaherpesvirus infection requires IFNgamma.

  2005cites this paper
• Dendritic cell fusion vaccines for cancer immunotherapy

  2005cites this paper
• Cross‐presentation of a CMV pp65 epitope by human dendritic cells using bee venom PLA2 as a membrane‐binding vector

  2005cites this paper
• The maturation of murine bone marrow-derived dendritic cells by tumor lysate uptake in vitro is not essential for cancer immunotherapy

  2005cites this paper
• DC infection promotes antiviral CTL priming: the 'Winkelried' strategy.

  2005cites this paper
• Efficient Responses in a Murine Renal Tumor Model by Electroloading Dendritic Cells With Whole-Tumor Lysate

  2005cites this paper
• Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death

  2005cites this paper
• Aus der Medizinischen Universitätsklinik Tübingen

  2004cites this paper
• An APC for every occasion: induction and expansion of human Ag-specific CD4 and CD8 T cells using cellular and non-cellular APC.

  2004cites this paper
• Augmentation of antitumor immune responses after adoptive transfer of bone marrow derived from donors immunized with tumor lysate-pulsed dendritic cells.

  2004cites this paper
• Highly Successful Therapeutic Vaccinations Combining Dendritic Cells and Tumor Cells Secreting Granulocyte Macrophage Colony-stimulating Factor

  2004cites this paper
• Breast carcinoma cell lysate-pulsed dendritic cells cross-prime MUC1-specific CD8+ T cells identified by peptide-MHC-class-I tetramers.

  2004cites this paper
• CD8+ cytotoxic T lymphocytes isolated from allogeneic healthy donors recognize HLA class Ia/Ib-associated renal carcinoma antigens with ubiquitous or restricted tissue expression.

  2004cites this paper
• Peyer's Patch Dendritic Cells Process Viral Antigen from Apoptotic Epithelial Cells in the Intestine of Reovirus-infected Mice

  2004cites this paper
• Statistical considerations for the design and analysis of the ELISpot assay in HIV-1 vaccine trials.

  2004cites this paper